Teaching Novel Values-Based Skills to Improve Long-Term Weight Loss

Overweight and Obesity Clinical Trial

Official title:

Teaching Novel Values-Based Skills to Improve Long-Term Weight Loss: A Randomized Trial Examining the Efficacy of a Weight Loss Maintenance Intervention Based on Acceptance and Commitment Therapy

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT04256850
• Other study ID #: R01DK120731
• Status: Active, not recruiting
• Phase: N/A
• Start date: February 19, 2020
• Est. completion date: September 30, 2024

Study information

• Verified date: October 2023
• Source: The Miriam Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This NIDDK funded R01 project is a randomized controlled clinical trial to compare the efficacy of an intervention based on Acceptance and Commitment Therapy (ACT) and a Self-Regulation (SR) intervention on weight loss maintenance over a 30-month period. All participants will first complete a well-validated online weight loss intervention (months 1-3 of the study). Participants who lose ≥4 kilograms of initial weight will then be randomly assigned to receive ACT or SR, with both conditions consisting of face-to-face, group-based intervention meetings and weekly email contact for 6 months.

Description:

Obesity is a major public health problem, and although short-term weight loss is achievable, individuals often regain the majority of weight that was lost. Current approaches have adjusted behavioral prescriptions and lengthened treatment contact in an effort to address this problem, with modest effect. This NIDDK funded R01 project is a randomized controlled clinical trial to compare the efficacy of an intervention based on Acceptance and Commitment Therapy (ACT) and a Self-Regulation (SR) intervention on weight loss maintenance over a 30-month period. All participants will first complete a well-validated online weight loss intervention (months 1-3 of the study). Participants who lose ≥4 kilograms of initial weight will then be randomly assigned to receive ACT or SR, with both conditions consisting of face-to-face, group-based intervention meetings and weekly email contact for 6 months. The ACT intervention will target a novel theoretically derived intervention target, values-consistent behavior, which will help align weight loss goals with personal values and foster internal motivation to continue with weight control efforts. Assessments will be at baseline, post-weight loss/pre-randomization, and then 6, 12, 18, 24, and 30-month follow-up (months from randomization). This project will be conducted at the Weight Control and Diabetes Research Center (WCDRC). The WCDRC is part of the Centers for Behavioral and Preventive Medicine at The Miriam Hospital in Providence, Rhode Island, and the Department of Psychiatry and Human Behavior at the Alpert Medical School of Brown University. This study is significant because it addresses weight loss maintenance - a critical barrier to treating obesity - and results of the study could be used to improve long-term weight loss outcomes and associated health benefits for treatment seeing overweight and obese adults.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 480
• Est. completion date: September 30, 2024
• Est. primary completion date: September 30, 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 25 Years to 70 Years

Eligibility

Inclusion Criteria:

• English language fluent and literate at the 6th grade level

• Body mass index (BMI) between 27.5 and 45 kg/m-squared

• Able to walk 2 city blocks without stopping

• Has reliable access to a computer with internet access

Exclusion Criteria:

• Currently participating in another weight loss program

• Currently taking weight loss medication

• Has lost =5% of body weight in the 6 months prior to enrolling

• Has been pregnant within the 6 months prior to enrolling

• Plans to become pregnant within 18 months of enrolling

• Has a heart condition, chest pain during periods of activity or rest, or loss of consciousness in the 12 months prior to enrolling

• Has any medical condition that would affect the safety of participating in unsupervised physical activity

• Has any condition that would result in inability to follow the study protocol, including terminal illness and untreated major psychiatric illness

Related Conditions & MeSH terms

• Overweight
• Overweight and Obesity
• Weight Loss

Intervention

Behavioral:
• Acceptance and Commitment Therapy (ACT)
Teaches acceptance, mindfulness, and values-based skills
• Self-Regulation (SR)
Teaches monitoring and reinforcement strategies designed to improve motivation and adherence to positive weight loss behavioral prescriptions.

Locations

Country	Name	City	State
United States	Weight Control and Diabetes Research Center	Providence	Rhode Island

Sponsors (1)

Lead Sponsor	Collaborator
The Miriam Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Weight Loss Maintenance	weight change from randomization to study end	30 months
Secondary	Waist Circumference	change in waist circumference from randomization to study end	30 months
Secondary	Objectively Measured Physical Activity Minutes Per Week	change in objectively measured physical activity from randomization to study end as measured by 7 days of wearing Actigraph accelerometer device	30 months